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The action of mimetic peptides on connexins protects fibroblasts
from the negative effects of ischemia reperfusion
Beverley J. Glass1, Rebecca G. Hu2, Anthony R. J. Phillips3,4 and David L. Becker2,*
ABSTRACT
Connexins have been proposed as a target for therapeutic treatment
of a variety of conditions. The main approaches have been by
antisense or small peptides specific against connexins. Some of
these peptides enhance communication while others interfere with
connexin binding partners or bind to the intracellular and extracellular
loops of connexins. Here, we explored the mechanism of action of a
connexin mimetic peptide by evaluating its effect on gap junction
channels, connexin protein levels and hemichannel activity in
fibroblast cells under normal conditions and following ischemia
reperfusion injury which elevates Cx43 levels, increases
hemichannel activity and causes cell death. Our results showed
that the effects of the mimetic peptidewere concentration-dependent.
High concentrations (100-300 μM) significantly reduced Cx43 protein
levels and GJIC within 2 h, while these effects did not appear until
6 h when using lower concentrations (10-30 μM). Cell death can be
reduced when hemichannel opening and GJIC were minimised.
KEY WORDS: Hemichannel, Gap junction, Ischemia Reperfusion,
Mimetic peptide
INTRODUCTION
Connexin (Cx) modulation has been recognised as a target for
therapeutic intervention in a number of diseases (Alldredge, 2008;
Bennett, 1994; Ormonde et al., 2012; Wei et al., 2004) and there are
nowa series of clinical trials targeting Cxs. The principal approaches
to functional modulation of Cx have so far been the use of antisense
oligodeoxynucleotides (Law et al., 2006; Mori et al., 2006;
O’Carroll et al., 2013a,b; Ormonde et al., 2012; Qiu et al., 2003)
or small peptides (Chaytor et al., 1997; Evans and Boitano, 2001;
Herve and Dhein, 2010; Hunter et al., 2005; Kjolbye et al., 2007;
O’Carroll et al., 2008; O’Quinn et al., 2011; Skyschally et al., 2013).
Peptide approaches have varied. For example, ACT-1 is a mimetic
peptide that reportedly interrupts binding partner interactionwith the
Cx43 PDZ2 domain (Ghatnekar et al., 2014, 2009; Ongstad et al.,
2013). Danegaptide (formerly known as GAP-134) is a dipeptide
said to activate gap junction (GJ) communication channels between
cells (Skyschally et al., 2013). Mimetic peptides that mimic the
extracellular loops of Cxs have also been reported to influence gap
junction and hemichannel function (Warner et al., 1995). However,
the exact mechanism of action leading to the protective effect seen
with Cx mimetic peptides is still undefined (Chen et al., 2015b).
Several in vitro studies in a broad range of cells and tissues have
resulted in three key theories as to how Cx mimetic peptides can
interrupt or inhibit GJ intercellular communication (GJIC) (Evans
and Boitano, 2001; Evans et al., 2012). These include: (1) Cx
mimetic peptide interaction with an undocked hemichannel (CxHC)
in the plasmamembrane, thereby preventing connexons docking and
GJ formation with other cells; (2) interacting with CxHCs or GJs and
altering channel gating; (3) interacting via the intercellular space
between the GJs leading to dissociation of the GJ plaques and
subsequent internalization and breakdown.
Here we explored the mechanism underlying the actions of a
mimetic peptide on GJ channels, Cx protein levels, and CxHC
activity in fibroblast cells under normal conditions and following
ischemia-reperfusion injury. Tissue ischemia is a major medical
problem that may occur in a number of organs such as the heart (e.g.
cardiac infarction), brain (e.g. ischemic stroke), and skin (e.g.
pressure ulcer). The common feature is a period of blood flow
restriction to the tissue resulting in deprivation of oxygen, glucose
and other nutrients needed for cell survival. The profound damage,
however, occurs during the reperfusion phase. This is when the
blood supply returns and causes inflammation and oxidative
damage to the tissue that has been deprived of oxygen for a
period of time (García-Dorado et al., 2004). Often this damage
spreads beyond the initial ischemic region and causes cell death in
the adjacent area. The spread of cell death has been attributed to
GJIC in stroke models (Cotrina et al., 1998) and models of heart
attack (García-Dorado et al., 2004) whilst negative effects of CxHC
activity on cell viability have been reported in models of stroke
(Cotrina et al., 1998; García-Dorado et al., 2004; Orellana et al.,
2010; Thompson et al., 2006). The ‘bystander’ effect model
suggests that death signals can spread laterally through GJs from
dying cells into their healthy neighbour cells (Mao et al., 2009;
Zhang et al., 2013). However, some reports also attribute cell death
in ischemia-reperfusion models to the opening of undocked CxHC,
causing blood vessel leakiness and release of ATP leading to
activation of purinergic receptors (Danesh-Meyer et al., 2012;
Clarke et al., 2009; Davidson et al., 2013; Orellana et al., 2010;
Poornima et al., 2012; Thompson et al., 2006).
Cx mimetic peptides have demonstrated therapeutic benefit for
protecting neuronal cells in the event of ischemia reperfusion
(Davidson et al., 2013). Application of Cx mimetic peptides can
significantly reduce the cell damage that occurs in an in vitro and an
in vivo spinal cord injury model (O’Carroll et al., 2008, 2013a,b).
Building on this research, using a model of cerebral ischemia in
foetal sheep,Davidson and colleagues demonstrated thatCxmimetic
peptide could increase the survival rate of cells during ischemia
reperfusion and reduce seizure activity (Davidson et al., 2012).
Cardiac protection has also been noted in rat models of myocardial
infarction, where Cx mimetic peptides leading to a significantReceived 20 July 2015; Accepted 21 September 2015
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reduction of infarct size by over 60% (Hawat et al., 2012). However,
the precise mechanism of action of the peptides is still unknown.
There is no published work of which we are aware indicating that
Cx mimetic peptides reduce the extensive progressive damage often
seen in pressure ulcers. Repeated cycle of pressure and relief causes
severe tissue ischemia reperfusion damage in the skin, similar to the
damage seen in cerebral and cardiac ischemia reperfusion. If left
untreated, this will ultimately lead to the formation of pressure ulcer
and an open wound. There are currently no effective treatments for
this irreversible pressure ulceration and understanding how cell
death occurs and spreads will help in the discovery of a treatment to
reduce the impact of ischemia reperfusion damage.
In this study, we investigated the effect of Cx mimetic peptide
Gap27 on Cx43 GJ protein, CxHC protein levels and GJIC in 3T3
fibroblasts under normal conditions. GAP27 aligns 100% with a
part of the extracellular loop 2 of the Cx43 protein (Chaytor et al.,
1997) and has consistently been identified as an effective inhibitor
of GJIC. We show for the first time that this mimetic peptide can
cause a rapid reduction in both Cx43 and CxHC protein levels in
3T3 fibroblasts. This leads to attenuation in GJIC as well as CxHC
activity. Subsequently, we demonstrated in an in vitro model of
ischemia reperfusion, that targeting Cx hemichannels can protect
cells and minimise cell death.
RESULTS
Gap27 reduced Cx43 and CxHC levels in normal 3T3
fibroblasts
To determine the effect of Cx mimetic peptide on Cx43 GJ and
CxHC protein levels, 3T3 cells were treated with different doses of
Gap27 for 2 h or 6 h. In cells with no-treatment or scrambled
peptide (SP), Cx43 puncta were localised to the plasma membrane
between neighbouring cells and the perinuclear region which
corresponds to the Golgi compartment (Fig. 1A,B). After 2 h of
incubation with Gap27 (30, 100, 300 μM), there was a significant
reduction of Cx43 staining levels in comparison to no-treatment or
scrambled peptide (Fig. 1A). A slight decrease was also seen in the
cells treated with 10 μM of Gap27, although not statistically
significant (Fig. 1C). In the cells treated with Gap27 for 6 h, Cx43
levels were significantly less for all the doses and reached about
60% reduction of Cx43 protein levels compared to no-treatment or
scrambled peptide (Fig. 1D). This result was confirmed by western
blotting (Fig. 1E,F). Since there was no difference between no-
treatment and scrambled peptide, only no-treatment was included as
a control in subsequent experiments.
CxHC distribution patterns were studied using an antibody that
only binds to undocked Cx. CxHC puncta were much smaller in size
compared to the Cx43 labelling (Fig. 2). Similar to the observation
with Cx43, less CxHC staining was detected in the cells treated with
Gap27 compared to no-treatment at 2 h (Fig. 2A) and 6 h (Fig. 2C).
Significant reduction in CxHC levels was seen with Gap27 (30, 100,
300 μM) after 2 h (Fig. 2B) and in all the doses after 6 h incubation
(Fig. 2D).
Gap27 significantly reduced GJIC between fibroblast cells
Fluorescence recovery after photobleaching (FRAP) was performed
to assess the effect of Gap27 on GJIC between neighbouring cells
(Fig. 3). Cells were pre-treated with Gap27 (30 or 300 μM) for 2 h
prior to the FRAP experiment. Ten minutes after photobleaching of
calcein, fluorescence recovery was ∼60% in cells with no-treatment
or scrambled peptide (300 μM), whereas Gap27 (300 μM) treated
cells showed ∼30% fluorescence recovery. This suggests that GJIC
has been attenuated by Gap27 (300 μM). Such attenuation was not
observed in cells treated with Gap27 (30 μM).
The in vitromodel of ischemia reperfusion with significantly
reduced oxygen in culture media
To investigate the GJIC and CxHCs activity during ischemia
reperfusion stress, a well characterised in vitro model of ischemia
Fig. 1. Gap27 reduced Cx43 protein levels in normal 3T3 fibroblasts.
(A,B) Representative images of cells with no treatment (NT), 100 µM
scrambled peptide (SP) treated, or treated with increasing doses of Gap27 for
(A) 2 h or (B) 6 h. Cells were immunolabeled for Cx43 (green, white arrows)
and nuclei (blue) identified by Höechst. (C,D) Cx43 labelling intensity was
quantified at (C) 2 h and (D) 6 h. (E) Western blots of Cx43 protein levels at 6 h
after Gap27 treatment. Alpha tubulin was included as a loading control
housekeeping protein. (F) Intensity of the Cx43 band was presented in ratio to
alpha tubulin. Data are means±s.e.m. (n=3). *P<0.01, **P<0.001, #P<0.05
compared with NT, one-way ANOVA. Scale bar=50 µm.
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reperfusion was replicated (Pringle et al., 1997). Fibroblast cells
were subjected to oxygen-glucose deprivation followed by
reperfusion in glucose and reoxygenation (OGDR). Partial
pressure of oxygen within the OGDR media was measured using
the fibre oxygen (FOXY) probe, and the oxygen levels were reduced
from 20% to less than 5% (Fig. S1).
Cx43 and CxHC protein levels significantly increased in
fibroblast cells after OGDR insult
Cx43 and CxHC protein levels were examined in fibroblast cells
under normal culture conditions and subjected to OGDR insult. In
cells subjected to OGDR insult, increasing levels of Cx43 and
CxHC were observed at 4 and 24 h after reperfusion and compared
to the control cells (Fig. 4A-D). This was also confirmed by western
blotting against Cx43 proteins (Fig. 4E-F).
Gap27 prevented the increase of GJIC after OGDR insult
Since upregulation of Cx43 and CxHC levels were seen after OGDR
insult, FRAP was performed to investigate GJIC between adjacent
cells. In cells subjected toOGDR insult and reperfused for 4 h (Fig. 5,
black line), the recovery rate of fluorescence after photobleachingwas
significantly faster than the normal fibroblasts (Fig. 5, red line),
indicating increased GJIC. Treatment of Gap27 (100 μM; Fig. 5, grey
solid line) after OGDR reverted the OGDR-induced increase whilst
Gap27 (300 μM; Fig. 5, grey dash line) reduced the fluorescence
recovery rate further than that seen in normal fibroblasts.
Gap27 reduced the opening of CxHC after OGDR insult
PI uptake assay was performed on low confluence fibroblasts to
assess CxHC activity after OGDR insult. Cells were seeded at low
confluency to minimise cell-to-cell contact and therefore CxHC at
the plasma membrane remained undocked. PI is a positively
charged dye which is normally excluded from live cells unless they
open HC (or the cell membrane is compromised) and was used here
as extracellular fluorescent permeability tracer to examine CxHC
activity. Under normal culture conditions, almost all of the cells
took up calcein-AM and converted it to calcein (Fig. 6B, No
OGDR). OGDR stress caused more PI entry into the cells, peaking
at 5 h after OGDR insult (Fig. 6, 300 min). At the same time, calcein
signal disappeared. Incubation with Gap27 (all doses) significantly
reduced the cellular uptake of PI with many cells remained calcein
positive (Fig. 6), although some PI positive cells were still evident.
Reducing Cx43 protein levels minimised cell death after
OGDR insult
Effect of the OGDR insult on cell viability was investigated in wild-
type 3T3 fibroblasts or 3T3 fibroblasts with reduced Cx43 and
CxHC protein levels following either Cx43shRNA transduction
(Fig. S1) or Gap27 treatment. After OGDR insult, viability of wild-
type fibroblasts significantly dropped at 4 h and further reduced at
24 h (Fig. 7A). Similar observation was noted for fibroblasts
transduced with empty vector P.Sup (Fig. 7B). However, when
Cx43 expression was reduced by either Cx43shRNA (Fig. 7C) or
Fig. 2. Gap27 reduced CxHC protein levels in normal 3T3 fibroblasts.
(A,C) Representative images of 3T3 cells with no treatment (NT), or treated
with increasing doses of Gap27 for (A) 2 h or (C) 6 h. Cells were
immunolabelled for CxHC (green, white arrows) and nuclei (blue) identified by
Höechst. (B,D) CxHC labelling intensity was quantified at (B) 2 h and (D) 6 h.
Data are means±s.e.m. (n=3). *P<0.05, **P<0.01 compared with NT, one-way
ANOVA. Scale bar=50 µm.
Fig. 3. High concentration of Gap27
reduced GJIC in normal 3T3 fibroblasts.
(A) Representative images of FRAP experiment in
cells treated with Gap27 (30, 300 µM), scrambled
peptide (300 µM), or no-treatment for 2 h. The
bleached cell was circled in red. (B) The recovery
profiles of fluorescence after FRAP. Data are
means±s.e.m. (n=3). **P<0.01 compared with NT,
one-way ANOVA. Scale bar=10 µm.
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Gap27 (300 μM) treatment (Fig. 7D), cell viability was significantly
increased to levels almost comparable to the cells without OGDR
insult at both time points. Gap27 (30 μM) also showed higher cell
viability in comparison to OGDR with no-treatment, but there was
still considerable decrease in cell viability.
DISCUSSION
In this study, we investigated the mechanism of action of a connexin
extracellular loop mimetic peptide on GJ and CxHCs in normal
fibroblasts in vitro. We showed, for the first time, that the
representative mimetic class peptide, Gap27, can significantly
reduce the levels of both CxHC and Cx43 GJ protein in a
concentration dependent manner, and subsequently reduced GJIC.
Although it has been shown by an electrophysiolgical approach that
mimetic peptides bind to CxHC prior to blockage of GJ (Evans
et al., 2012; Kwak and Jongsma, 1999), we provided evidence that
Gap27 can downregulate CxHC protein levels (Fig. 2) and reduce
CxHC activity (Fig. 6). Decreased CxHC expression can also, to
some extent, account for the downregulation of Cx43 GJ protein as
one precedes the other. Maximum reduction of CxHC levels was
rapidly achieved at 2 h after mimetic peptide (30 μM) treatment,
with 67% reduction for CxHC levels (Fig. 2B). At this time there
was only a 40% reduction in Cx43 protein (Fig. 1C). Higher
concentration (100-300 μM) of Gap27 (Fig. 1C) or longer
incubation time (Fig. 1D) was required before further
downregulation of Cx43 GJ could be achieved. In support of the
immunocytochemistry result, reduced GJIC at 2 h post treatment
was only seen with high concentration of mimetic peptide (300 μM)
and not with the low concentration (30 μM) (Fig. 3).
In GJ formation, the two extracellular loops of Cxs from opposing
cells interact and dock to form a channel. Each loop has three
conserved cysteine residues joined by at least one disulphide bond.
It is doubtful that mimetic peptides can disrupt GJ by breaking this
strong bond. Indeed, it has been shown in cells transfected with
fluorophore-tagged Cx that GJ internalise as a channel into just one
of the two cells (Jordan et al., 2001). Electrophysiological studies
using the mimetic peptide Gap26 also demonstrated that the CxHC
is the first target of mimetic peptides, before further incubation
prevents these CxHCs from docking to their neighbours and
ultimately inhibiting GJIC (Desplantez et al., 2012).
The effects of the Gap27 mimetic peptide on Cx43 GJ protein
levels have been reported in both in vitro and in ex vivo spinal cord
segment models (Chen et al., 2015a; O’Carroll et al., 2008). A
markedly reduced expression of Cx43 was observed when
compared to the scrambled peptide. In HeLa cells stably
transfected with Cx43-GFP, decreased GJIC was reported but
without significant difference in the number of Cx43 plaques
between cells treated with mimetic peptide and untreated control
cells (Berman et al., 2002). In that study, however, the cells
were treated with sodium butyrate for 18 h prior to the experiment
to enhance protein expression and therefore cannot directly be
compared to natural Cx43 expression in cells. In addition, in those
studies the cells were only treated with mimetic peptide for 1.5 h,
which may be too early to detect any obvious decrease in Cx43
expression given that the Cx43 half-life is about 2-3 h (Laird, 2006).
Equally in some other studies, incubation with mimetic peptides for
1.5 h caused decreased GJIC but not Cx43 expression, which again
might not be expected in this short time frame (Wright et al., 2009).
The same group also reported similar finding in the rat aortic A7r5
smooth cell line following 4 h incubation with Gap26 or Gap27
treatments, although a downward trend was observed for the relative
fluorescence levels of Cx43 in comparison to the controls (Martin
et al., 2005). As other studies have performed similar experiments
without using reduced serum media [it has been well documented
that proteases within serum can rapidly digest the peptides (Wright
Fig. 4. OGDR insult significantly increased Cx43 and CxHC protein levels
in 3T3 fibroblasts. (A,B) Representative images of (A) Cx43 (green) and
(B) CxHC (green) proteins in control 3T3 fibroblasts and that have undergone
OGDR stress. (C,D) Labelling intensity of (C) Cx43 and (D) CxHC were
quantified. Data are means±s.e.m. (n=4). *P<0.05, t-test. (E,F) Western blots
and quantification of (E) Cx43 in control cells and (F) cells subjected to OGDR
insult (OGDR WT 3T3) and reperfused for various time period. Alpha tubulin
was stained as loading control and used for normalisation. Pixel intensity of the
bands was measured. Data are means±s.e.m. n=3, **P<0.01 compared with
0 h, one-way ANOVA. Scale bar=20 µm.
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et al., 2009)], the sera can greatly reduce the efficacy and longevity
of the peptides. It is likely that the duration of treatment,
experimental setup, and the cell types used will all play a role in
the effect of mimetic peptide on Cx protein levels.
After establishing that the Gap27 mimetic peptide reduced CxHC
levels and subsequently reduces Cx43 GJ levels and GJIC in our
experiments, we investigated the therapeutic potential of mimetic
peptide in an in vitro model of ischemia+reperfusion. A significant
elevation of CxHC and Cx43 GJ protein levels was evident 24 h
after OGDR insult (Fig. 4), concomitant with increased CxHC
activity (Fig. 6) and GJIC (Fig. 5). These changes correlated with a
decrease in cell viability (Fig. 7A), which we confirmed was largely
a result of increased connexin-based communication. In cells
transduced with Cx43shRNA, cell viability after OGDR was almost
the same as without OGDR (Fig. 7C).
Our results are in agreement with other studies that have
demonstrated reduced cell death after OGDR upon treatment with
carbenoxalone (a non-specific inhibitor of gap junction
communication) or Cx43-specific antisense (Frantseva et al.,
2002). Based on studies in the heart and brain, it was proposed
that metabolic inhibition from an ischemic episode opens CxHCs
upon reperfusion, which accelerates cell death (Clarke et al., 2009;
Contreras et al., 2002; Davidson et al., 2013; Johansen et al., 2011;
Orellana et al., 2010; Thompson et al., 2006). In addition, increases
Fig. 5. High concentration of
Gap27 prevented the perturbed
GJIC at 4 h after OGDR insult.
(A) Representative images of the
FRAP experiment. The bleached cell
was circled in red. (B) The recovery
profiles of fluorescence after FRAP.
Data are means±s.e.m. (n=4).
**P<0.01 compared with No OGDR,
##P<0.01, ###P<0.001, ++P<0.01,
+++P<0.001, ++++P<0.0001 compare
with OGDR, one-way ANOVA. Scale
bar=25 µm.
Fig. 6. PI uptake in low confluence cells
subjected to OGDR insult and Gap27
incubation. (A) Representative images of
3T3 fibroblasts after OGDR insult andGap27
treatment, up to 5 h after OGDR. Live cells
were identified by Calcein AM (green) and
cells with open CxHC showed permeation of
PI (red). (B) Quantification of PI-positive
cells, as a percentage of Calcein-AM positive
cells in the first frame of time-lapse. Data are
means±s.e.m. (n=4). **P<0.01, ***P<0.001,
****P<0.0001 compare with No OGDR,
one-way ANOVA. Scale bar=100 µm.
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in Cx43 expression and GJIC were suggested to play a role in the
spread of damage through the ‘bystander’ effect when cell death
signals spread laterally through GJ from dying cells to their healthy
neighbours (Cotrina et al., 1998; Danesh-Meyer et al., 2012;
Davidson et al., 2012; Mao et al., 2009; Zhang et al., 2013).
Similar to the various agents that minimise connexin expression
and communication, the mimetic peptide rescued the cells after
OGDR insult in a concentration dependent manner (Fig. 7D).
CxHCs opened after OGDR and allowed PI to enter the cells over
the period of reperfusion (Fig. 6). Although loss of membrane
integrity may also lead to PI permeation, it is unlikely to be the case
here because cells still appeared healthy with no signs of rounded
morphology or detachment at 5 h after OGDR. The fact that PI
permeation was prevented with treatment of both low and high
concentration of Gap27 also indicates that PI enters into the cell
through open CxHC. Cell viability had actually dropped by 4 h after
OGDR (Fig. 7D) as shown byMTT assay. High concentration (100-
300 μM) of Gap27 dampened GJIC (Fig. 5) thereby reducing cell
death to some extent (Fig. 7D).
In conclusion, we have confirmed that Cx43 plays an important
role in cell death during ischemia-reperfusion in fibroblast cells.
This is in comparable to that described in experiments with heart
and brain cells. We established that the Gap27 mimetic peptide
could rapidly reduce CxHC protein levels within 2 h with
concentration as low as 30 μM, while higher concentrations of at
least 100 μM or longer treatment time is required for
downregulation of Cx43 GJ protein. Reduction in CxHC and
Cx43 GJ protein leads to a decrease GJIC and can protect the cells
from ischemia reperfusion damage. The Gap27 mimetic peptide
may serve as a potential therapeutic agent for treating connexin-
based disorders and perhaps preventing the progression of pressure
ulcer development by dampening the damage induce by repetitive
episodes of ischemia reperfusion.
MATERIALS AND METHODS
Reagents
All chemicals and reagents were purchased from Sigma-Aldrich unless
otherwise stated. Mimetic peptide Gap27 shares a conserved sequence
homology to the second extracellular loop (E2) of Cx (amino acid 204-214;
SRPTEKTIFII) and was custommade with 98% purity (Thermo Scientific).
Scrambled peptide (SP) (RFKSPSLCTTDEV) was based on a previous
publication (O’Carroll et al., 2008). Peptides were prepared in reduced serum
media Opti-Minimal Essential Medium (OptiMEM) supplemented with 1%
donor bovine serum (DBS), abbreviated toOptiMEM+.OptiMEM+ allowed
cells to continue to grow and proliferate while minimising breakdown of
mimetic peptide by proteases.
Rabbit anti-CxHC is a custom made antibody (affinity purified) against a
highly conserved region of the first extracellular loop (E1) of Cx, sequence
ESAWGDEQSAFRCNTQQPGC.
Rabbit anti-Cx43 was purchased from Sigma-Aldrich (C6219).
Cell culture, retroviral constructs, and transduction
Mouse fibroblast cells, NIH 3T3 (ATCC #CRL-1658) were cultured with
Dulbecco’s Modified Essential Medium (DMEM) supplemented with 10%
DBS, 100 U/ml penicillin and 100 µg/ml streptomycin in 5%CO2 and 95%air
at 37°C. 3T3 cells were transduced with aCx43-specific shRNA
(Cx43shRNA; sequence GGTGTGGCTGTCAGTGCTC) construct gifted
by W. H. Moolenaar (van Zeijl et al., 2007), or a retroviral empty vector
pSuppressor (p.Sup) from Imgenex. The GP2-293 packaging cell line
(Clonetech) was transfected by calcium phosphate precipitation with 5 µg
pMD.G envelope plasmid, 10 µg pBSII SK-carrier plasmid (Stratagene), and
15 µg retroviral plasmid containing either Cx43shRNA or the empty vector p.
Sup. Viral media was collected to infect the 3T3 cells for 48 h, with fresh viral
media being replaced every 12 h. Transduced cells were selected based on
resistance to 2 µg/ml puromycin (Cx43shRNA)or 500 µg/ml geneticin (empty
vector). The first three passages of transduced cells were used for experiments.
Mimetic peptide incubation
When cells were subjected to 2 h incubation, a single dose of Gap27 (10, 30,
100, 300 µM) or scrambled peptide (100 µM) was applied. For 6 h
Fig. 7. Reducing Cx43 expression preserved cell
viability at 4 h and 24 h after OGDR insult.
(A-C) Cell viability measurements of (A) wild-type
3T3 fibroblasts, (B) 3T3 fibroblasts transduced with
empty vector (EV) or (C) Cx43shRNA. n=3,
*P<0.05, t-test. (D) Cell viability measurements of
wild-type 3T3 fibroblasts treated with Gap27 (30 μM
or 300 μM). n=4, *P<0.05 comparewith control, one-
way ANOVA. Data are means±s.e.m.
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incubation, fresh media containing peptides was replaced every two hours.
A control without peptide was included.
In vitro ischemia reperfusion model
Cells were subjected to ischemia reperfusion by exposing them to oxygen-
glucose deprivation/reoxygenation (OGDR). Briefly, DMEM (glucose and
serum free) that had been effervesced with 5% CO2 and 95% N2 for 1 h was
applied to the cells. Cells were then placed inside a sealed chamber with an
atmosphere of 5%CO2 and 95%N2 for 1.5 h, followed by re-oxygenation in
fresh OptiMEM+ at 37°C in 5% CO2 and 95% air for 0, 1.5, 4 or 24 h.
Oxygen levels in the media were measured using a fibre optic oxygen
(FOXY) probe (Ocean Optics).
Immunofluorescence
Cells were grown to confluence in 8-well chamber slides (Millicell EZ slide,
Millipore) and subjected to treatments. Cells were then fixed in 4%
paraformaldehyde for 15 min, permeablised with 0.1% Triton X-100 for
15 min, and blocked with 0.1 M lysine-PBS for 30 min. Rabbit anti-Cx43
(1:4000) was applied for 1 h at room temperature or rabbit anti-CxHC
(1:1000) overnight at 4°C, followed by goat anti-rabbit Alexa 488 (1:500;
Life Tech) for 1 h. A mixture of Höechst 33258 and 33342 (1:50,000) was
applied to stain the nuclei. Slides were coverslipped in Citifluor and imaged
under a confocal microscope (Upright SPE, Leica). All images were
acquired using identical parameters. Cx or GJ profile was analysed using
ImageJ (version 1.46r, Wayne Rasband, NIH) by setting a threshold to
binary segregate connexin puncta and background, and the number of nuclei
was counted. All images were processed using identical parameters and data
was presented as connexin pixel area per cell.
Western blots
Cells were grown to confluence in 6-well plates and subjected to treatments.
Cells were lysed using cold radio immunoprecipitation (RIPA) buffer
supplemented with protease and phosphatase inhibitor cocktail (Roche).
Lysates were sonicated for 30 min, centrifuged at 4°C for 10 min and the
supernatant was collected. Total proteins were measured by BCA assay
(Thermo Scientific). Equal amounts of protein were denatured with
Laemmli buffer (Bio-Rad) and resolved in 10% SDS-PAGE gel (Bio-
Rad), then transferred to nitrocellulose membrane. The membrane was
blocked in 1% non-fat milk in PBS-Tween for 1 h at room temperature, and
incubated overnight at 4°C with rabbit anti-Cx43 (1:4000). Subsequently,
goat anti-rabbit (1:1000) conjugated with horseradish peroxidise was
applied for 1 h. Alpha tubulin (1:2000 for 1 h; Abcam, ab64332) was used
as a housekeeping protein. Signal was detected using West Pico
Chemilluminescent Substrate (Thermo Scientific) and imaged on a
ChemiDoc™ (Bio-Rad). Band intensity was analysed using ImageJ. All
protein collection for western blots was repeated in triplicate.
Cell viability assay –MTT
10,000 cells per well were cultured in 96-well plates and subjected to OGDR
insult, followed by the MTT assay [3-(4, 5-dimethylthiazol-2-yl)-2,
5-diphenyl tetrazolium bromide] according to the manufacturer’s
instructions (Millipore). Briefly, 10 µl of MTT solution (5 mg/ml in PBS)
was added to the culture media in each well. After 4 h of incubation at 37°C,
100 µl of isopropanol with 0.04 N hydrochloric acid (HCl) was added to
each well. Absorbance was measured on a microplate spectrophotometer
(Spectra Max 340; Molecular Devices) at a test wavelength of 570 nm and a
reference wavelength of 630 nm. Absorbances were normalised to the
untreated cells at 0 h after reperfusion (i.e. 100% viability) and presented as
percentage of viability.
Communication assay – fluorescent recovery after
photobleaching (FRAP)
FRAPwas performed to investigate GJIC between adjacent cells. Cells were
grown to confluence in glass bottom 35 mm2 dishes and subjected to OGDR
insult. After the insult, cells were incubated with Gap27 (100 or 300 µM) or
left untreated in optiMEM+. A control without OGDR was included. After
4 h of treatment, calcein-AM (1 µl/1000 µl media) was applied for 20 min.
The cells were then washed 3× in PBS and replaced with fresh OptiMEM+
containing propidium iodide (PI) and Gap27 or OptiMEM+ only. FRAP
images were taken on a confocal microscope with temperature and gas
controlled chamber (5% CO2 and 95% air at 37°C). A zoomed region of
interest (ROI) covering a connected cell was bleached of its fluorophorewith
high laser power and subsequently imaged at a rate of 1.635 s per frame. The
speed of fluorescent recovery was quantified using ImageJ.
CxHC activity assay during OGDR
PI uptake assay was used to assess CxHC activity. Cells were grown to low
confluence to ensure no cell-to-cell contact and therefore CxHC on the
plasma membrane remained undocked. Cells were subjected to OGDR
insult, followed by 20 min incubation with calcein-AM. The cells were
then washed 3× in PBS and replaced with fresh OptiMEM+ containing PI
and Gap27 (30, 100 or 300 µM) or OptiMEM+ alone. A control with no
OGDR insult was included. Images were taken on an Olympus inverted
microscope (Olympus 1X81) with temperature and gas controlled chamber
(5% CO2 and 95% air at 37°C) every 30 min for 5 h. PI positive cells were
counted and expressed as a percentage of calcein positive cells in the first
frame taken.
Bystander effect assay during OGDR
Cells were grown to confluence to ensure GJ formation between adjacent
cells. After OGDR insult, cells were treated with Gap27 (10, 30, 100, 300 or
1000 µM), 100 µM scrambled peptide, or left untreated in OptiMEM+ only.
A control without OGDR insult was included. After 4 h of treatment,
calcein-AM was applied for 20 min. The cells were then washed 3× using
PBS and replaced with OptiMEM+ containing PI and Gap 27or OptiMEM+
only. Images were taken on the Olympus 1X81microscopewith temperature
and gas controlled chamber (5% CO2 and 95% air at 37°C) every hour for
24 h. PI positive cells were counted and expressed as a percentage of calcein
positive cells in the first frame taken.
Statistics
Statistical comparisons were made using either a one-way analysis of
variance (ANOVA) or independent-samples t-test using SPSS Statistics
(version 21, IBM). Data was tested for normality (Shapiro–Wilk test) and
equal variances (Levene test) before statistical comparisons were carried
out. In time-lapse experiments, the null hypothesis was rejected using a
multivariate analysis of variance (MANOVA). The Dunnett post hoc test
(against the control sample) or Tukey post hoc test were performed if data
proved significant. All experiments were independently repeated for 3×. All
data are presented as mean±s.e.m.
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